Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
PEG-MGF and Acetic Acid Mix

PEG-MGF Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

⚠ Use acetic acid — not bacteriostatic water PEG-MGF is insoluble or unstable in standard BAC water. Manufacturer protocols require reconstitution in dilute acetic acid (0.1%) — or, for IGF-1 variants, 50 mM acetic acid. Volumes shown below refer to acetic acid, not water.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example PEG-MGF Titration Schedule

ItemDetails
Community dose200 mcg 2–3× per week
TimingPost-workout (rest-day note is source-contradicted)
Cycle4–8 weeks + equal rest

Never tested in any biological system — no animal, no in vitro study of PEG-MGF exists; its half-life is unmeasured (sources contradict: 48 h vs 5 days). Vendor timing guidance is internally inconsistent (post-exercise vs rest-day). The parent peptide's activity already failed replication.

Possible vial strengths:

What Is It?

PEG-MGF

Pegylated mechano growth factor variant.

Acetic Acid (0.1%)

A dilute solution of acetic acid (typically 0.1% for most peptides, or 50 mM for IGF-1 variants) used to reconstitute peptides that are insoluble or unstable in standard bacteriostatic water. PEG-MGF requires an acidic carrier to dissolve fully and remain stable — plain BAC water will not work and may damage the peptide.

How To Mix PEG-MGF

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw Acetic Acid

Draw the selected amount of 0.1% acetic acid.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

PEG-MGF Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

PEG-MGF is the pegylated form of Mechano Growth Factor — the 24-amino-acid C-terminal E-peptide of the IGF-1Ec splice variant, with polyethylene-glycol (PEG) chains attached. Like native MGF, it's studied for activating muscle satellite (stem) cells, the early trigger of muscle repair; the PEG is simply what makes it last long enough to be practical. In short, it's the usable, longer-acting version of MGF — see the native MGF page for the unmodified peptide.
In research references PEG-MGF is dosed in micrograms — commonly around 200–400 mcg subcutaneously. Because the PEG chain greatly extends its duration, it doesn't need the immediate, into-the-muscle, every-session timing of native MGF; it's often used after training and on a less frequent schedule. These are research-reference figures, not an approved protocol, and the right approach is a clinical decision.
Add bacteriostatic water to the dry vial slowly and swirl — don't shake. For example, a 2 mg vial + 1 mL of water gives 2 mg/mL (2,000 mcg/mL); a 300 mcg dose is then 0.15 mL, which is 15 units on a U-100 insulin syringe. Use the calculator above to match your real vial size (2 mg is common) and target dose. Doses are in micrograms, so draw carefully — small volume errors are a large share of the dose.
Versus native MGF, the only change is the PEG chain, which stretches a half-life of about 5–7 minutes up to hours — long enough to inject subcutaneously and circulate, rather than having to go intramuscularly into the worked muscle. Versus IGF-1 LR3, the difference is the job: PEG-MGF's E-peptide mainly activates satellite cells to multiply (the early repair phase) through a pathway separate from the classic IGF-1 receptor, whereas IGF-1 LR3 acts on the IGF-1 receptor to drive growth and differentiation. They're different tools, and how anyone might pair them is a clinical decision, not something a calculator should merge.
PEG-MGF's bodybuilding reputation runs ahead of the evidence: pegylation fixed MGF's short-half-life problem, but the muscle-repair effects still come from cell and animal studies, with no human clinical trials of PEG-MGF. Reported effects are mostly local injection reactions, and because it sits on the IGF-1 pathway the general IGF-1 cautions apply — including avoiding it with active cancer. It's not FDA-approved, is sold for research only, and is banned by WADA under the S2 growth-factor category. Store the dry vial refrigerated and out of light; once reconstituted, keep it cold and use within a few weeks.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides